ARCHIVES

Accelerated Approval In Oncology Shaves A Year Off Development Time, FDA Data Show

This article is from The Cancer Letter archive.

Vol. 35 No. 40 | October 30, 2009

Download PDF Visit The Full Archive

Related Articles

LeMaistre Blasts “Death Merchants’ In tobacco Industry

May 5, 1989

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

PDQ Evaluation to Cost NCI More Than Reported

June 29, 1990

Feinstein Reintroduces New National Cancer Act

June 13, 2003

Bailer NEJM “Irresponsible, Purposely Misleading,” Ignored Facts, DeVita Tells NCA

May 23, 1986

BSA Eliminates Second Review For P01 Grants; R01Payline To increase to 24th Percentile

November 23, 1997